 TEANECK, N.J.--BUSINESS WIRE--Phibro Animal Health Corporation Nasdaq:PAHC today announced financial results for its fourth quarter and fiscal year ended June 30, 2021, and provided financial guidance for the year ending June 30, 2022. Highlights for the three months ended June 30, 2021 compared to the three months ended June 30, 2020 Net sales of 220 million, an increase of 34 million, or 19 Net income of 17 million, an increase of 12 million, or 203 Diluted EPS of 0.42, an increa 